BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang B, Zhang B, Zhang Z, Huang Z, Chen Y, Chen M, Bie P, Peng B, Wu L, Wang Z, Li B, Fan J, Qin L, Chen P, Liu J, Tang Z, Niu J, Yin X, Li D, He S, Jiang B, Mao Y, Zhou W, Chen X. 42,573 cases of hepatectomy in China: a multicenter retrospective investigation. Sci China Life Sci. 2018;61:660-670. [PMID: 29417360 DOI: 10.1007/s11427-017-9259-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Yan H, He N, He S. HCG15 is a hypoxia-responsive lncRNA and facilitates hepatocellular carcinoma cell proliferation and invasion by enhancing ZNF641 transcription. Biochemical and Biophysical Research Communications 2022;608:170-6. [DOI: 10.1016/j.bbrc.2022.03.143] [Reference Citation Analysis]
2 Huang Q, Chen Y, Lin K, Sun C, Zheng S, Chen J, Wang Y, Zhou Y, Zhou W, Liu J, Zeng Y. Redefining Hepatocellular Carcinoma Staging Systems Based on the Bile Duct Invasion Status: A Multicenter Study. Front Oncol 2021;11:673285. [PMID: 34722235 DOI: 10.3389/fonc.2021.673285] [Reference Citation Analysis]
3 Zhao Y, Zhang L, Zhang Y, Meng B, Ying W, Qian X. Identification of hedgehog signaling as a potential oncogenic driver in an aggressive subclass of human hepatocellular carcinoma: A reanalysis of the TCGA cohort. Sci China Life Sci 2019;62:1481-91. [PMID: 31313086 DOI: 10.1007/s11427-019-9560-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Zhang EL, Huang ZY, Chen XP. Rationality and necessity of vascular stapler application during liver resection (Review). Exp Ther Med 2021;21:498. [PMID: 33791007 DOI: 10.3892/etm.2021.9929] [Reference Citation Analysis]
5 Su Q, Wang H. Long non-coding RNA 01559 mediates the malignant phenotypes of hepatocellular carcinoma cells through targeting miR-511. Clin Res Hepatol Gastroenterol 2021;45:101648. [PMID: 33588099 DOI: 10.1016/j.clinre.2021.101648] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Liu Y, Liu R, Zhao J, Zeng Z, Shi Z, Lu Q, Guo J, Li L, Yao Y, Liu X, Xu Q. LncRNA TMEM220-AS1 suppresses hepatocellular carcinoma cell proliferation and invasion by regulating the TMEM220/β-catenin axis. J Cancer 2021;12:6805-13. [PMID: 34659569 DOI: 10.7150/jca.63351] [Reference Citation Analysis]
7 Wang JC, Hou JY, Chen JC, Xiang CL, Mao XH, Yang B, Li Q, Liu QB, Chen J, Ye ZW, Peng W, Sun XQ, Chen MS, Zhou QF, Zhang YJ. Development and validation of prognostic nomograms for single large and huge hepatocellular carcinoma after curative resection. Eur J Cancer 2021;155:85-96. [PMID: 34371445 DOI: 10.1016/j.ejca.2021.07.009] [Reference Citation Analysis]
8 Xu X, Chen R, Chen Q, An K, Ding L, Zhang L, Wang F, Deng Y. Efficacy of traditional herbal medicine versus transcatheter arterial chemoembolization in postsurgical patients with hepatocellular carcinoma: A retrospective study. Complement Ther Clin Pract 2021;43:101359. [PMID: 33711747 DOI: 10.1016/j.ctcp.2021.101359] [Reference Citation Analysis]
9 Jin S, Tan S, Peng W, Jiang Y, Luo C. Radiofrequency ablation versus laparoscopic hepatectomy for treatment of hepatocellular carcinoma: a systematic review and meta-analysis. World J Surg Oncol 2020;18:199. [PMID: 32787883 DOI: 10.1186/s12957-020-01966-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
10 Wu Z, Tang H, Wang L, Jin X, Lei Z, Yang P, Zhou J. Postoperative survival analysis of hepatocellular carcinoma patients with liver cirrhosis based on propensity score matching. BMC Surg 2022;22:103. [PMID: 35313836 DOI: 10.1186/s12893-022-01556-5] [Reference Citation Analysis]
11 Lin K, Huang Q, Zeng J, Ding Z, Wang L, Chen Z, Guo P, Zeng Y, Zhou W, Liu J. Clinical Significance of Alpha-Fetoprotein in Alpha-Fetoprotein Negative Hepatocellular Carcinoma Underwent Curative Resection. Dig Dis Sci 2021. [PMID: 33723698 DOI: 10.1007/s10620-020-06797-z] [Reference Citation Analysis]
12 Feng GS, Hanley KL, Liang Y, Lin X. Improving the Efficacy of Liver Cancer Immunotherapy: The Power of Combined Preclinical and Clinical Studies. Hepatology 2021;73 Suppl 1:104-14. [PMID: 32715491 DOI: 10.1002/hep.31479] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 20.0] [Reference Citation Analysis]
13 Liu H, Yin Y, Liu T, Gao Y, Ye Q, Yan J, Ha F. Long non-coding RNA PVT1 regulates the migration of hepatocellular carcinoma HepG2 cells via miR-3619-5p/MKL1 axis. Bosn J Basic Med Sci 2021;21:187-97. [PMID: 32156248 DOI: 10.17305/bjbms.2020.4641] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Yuan G, Li J, Yu S, Chen X, He S. Letter to the Editor: Predicting Postoperative Liver Dysfunction Based on Blood Derived MicroRNA Signatures. Hepatology 2019;70:1080-1. [PMID: 31034633 DOI: 10.1002/hep.30689] [Reference Citation Analysis]
15 Chen JG, Zhu J, Zhang YH, Chen YS, Ding LL, Chen HZ, Shen AG, Wang GR. Liver Cancer Survival: A Real World Observation of 45 Years with 32,556 Cases. J Hepatocell Carcinoma 2021;8:1023-34. [PMID: 34513745 DOI: 10.2147/JHC.S321346] [Reference Citation Analysis]
16 Huang Q, Lin K, Wang L, Zeng J, Liu H, Ding Z, Zeng Y, Liu J. Postoperative Adjuvant Transarterial Chemoembolization Improves Short-Term Prognosis of Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Propensity-Score Matching Study. Cancer Manag Res 2020;12:9183-95. [PMID: 33061610 DOI: 10.2147/CMAR.S270467] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Wang D, Zheng X, Fu B, Nian Z, Qian Y, Sun R, Tian Z, Wei H. Hepatectomy promotes recurrence of liver cancer by enhancing IL-11-STAT3 signaling. EBioMedicine 2019;46:119-32. [PMID: 31375423 DOI: 10.1016/j.ebiom.2019.07.058] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
18 Jin H, Pang Q, Fang M, Wang Y, Man Z, Tan Y, Liu H. Syt-7 overexpression predicts poor prognosis and promotes cell proliferation in hepatocellular carcinoma. Future Oncol 2020;16:2809-19. [PMID: 33052751 DOI: 10.2217/fon-2020-0262] [Reference Citation Analysis]
19 Shi Z, Liu R, Lu Q, Zeng Z, Liu Y, Zhao J, Liu X, Li L, Huang H, Yao Y, Huang D, Xu Q. UBE2O promotes hepatocellular carcinoma cell proliferation and invasion by regulating the AMPKα2/mTOR pathway. Int J Med Sci 2021;18:3749-58. [PMID: 34790050 DOI: 10.7150/ijms.63220] [Reference Citation Analysis]
20 Zhang T, Merle P, Wang H, Zhao H, Kudo M. Combination therapy for advanced hepatocellular carcinoma: do we see the light at the end of the tunnel? Hepatobiliary Surg Nutr 2021;10:180-92. [PMID: 33898559 DOI: 10.21037/hbsn-2021-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Cao N, Cai HJ, Sun XX, Liu DL, Huang B. Application of curved ablation in liver cancer with special morphology or location: Report of two cases. World J Clin Cases 2020; 8(9): 1713-1720 [PMID: 32420306 DOI: 10.12998/wjcc.v8.i9.1713] [Reference Citation Analysis]
22 Zhang EL, Li J, Li J, Wang WQ, Gu J, Huang ZY. Sub-Classification of Cirrhosis Affects Surgical Outcomes for Early Hepatocellular Carcinoma Independent of Portal Hypertension. Front Oncol 2021;11:671313. [PMID: 34094970 DOI: 10.3389/fonc.2021.671313] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Wang L, Ke Q, Deng M, Huang X, Zeng J, Liu H, Yang Y, Zeng Y, Zhou W, Liu J. Adjuvant transarterial chemoembolization for patients with hepatocellular carcinoma after radical hepatectomy: a real world study. Scand J Gastroenterol 2019;54:1403-11. [PMID: 31686555 DOI: 10.1080/00365521.2019.1684986] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
24 Liu P, Xia P, Fu Q, Liu C, Luo Q, Cheng L, Yu P, Qin T, Zhang H. miR-199a-5p inhibits the proliferation of hepatocellular carcinoma cells by regulating CDC25A to induce cell cycle arrest. Biochem Biophys Res Commun 2021;571:96-103. [PMID: 34314996 DOI: 10.1016/j.bbrc.2021.07.035] [Reference Citation Analysis]
25 Zuo D, An H, Li J, Xiao J, Ren L. The Application Value of Lipoprotein Particle Numbers in the Diagnosis of HBV-Related Hepatocellular Carcinoma with BCLC Stage 0-A. J Pers Med 2021;11:1143. [PMID: 34834495 DOI: 10.3390/jpm11111143] [Reference Citation Analysis]
26 Luo P, Yin P, Xu G. Reply. Hepatology 2018;67:2483-4. [PMID: 29506319 DOI: 10.1002/hep.29868] [Reference Citation Analysis]
27 Ji J, Liu L, Jiang F, Wen X, Zhang Y, Li S, Lou J, Wang Y, Liu N, Guo Q, Jia Y, Gao C. The clinical application of PIVKA-II in hepatocellular carcinoma and chronic liver diseases: A multi-center study in China. J Clin Lab Anal 2021;35:e24013. [PMID: 34590755 DOI: 10.1002/jcla.24013] [Reference Citation Analysis]
28 Chen S, Wu Y, Qi H, Shen L, Ma W, Cao F, Diao Y, Wang T, Ou S, Fan W. Single-nodule hepatitis B virus-associated hepatocellular carcinoma smaller than 3 cm: two phenotypes defined by cluster analysis and their association with the outcome of ablation as the first-line therapy. Int J Hyperthermia 2021;38:120-9. [PMID: 33541160 DOI: 10.1080/02656736.2021.1876930] [Reference Citation Analysis]
29 Zhang EL, Cheng Q, Huang ZY, Dong W. Revisiting Surgical Strategies for Hepatocellular Carcinoma With Microvascular Invasion. Front Oncol 2021;11:691354. [PMID: 34123861 DOI: 10.3389/fonc.2021.691354] [Reference Citation Analysis]
30 Shen S, Zhang C, Ge M, Dong S, Xia L, He P, Zhang N, Ji Y, Yang S, Yu Y, Zheng J, Yu J, Xia Q, Chen G. PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation. Nat Cell Biol 2019;21:1436-48. [DOI: 10.1038/s41556-019-0409-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]